Association of post-transplantation anellovirus viral load with kidney transplant rejection in children

[1]  E. Puchhammer-Stöckl,et al.  Torque teno viral load reflects immunosuppression in paediatric kidney-transplanted patients—a pilot study , 2020, Pediatric Nephrology.

[2]  L. van der Hoek,et al.  Human anelloviruses: diverse, omnipresent and commensal members of the virome , 2020, FEMS microbiology reviews.

[3]  G. Kobbe,et al.  The value of Torque Teno Virus (TTV) as a marker for the degree of immunosuppression in adult patients after hematopoietic stem cell transplantation (HSCT). , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  S. Fafi-Kremer,et al.  Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation. , 2019, The Journal of infection.

[5]  M. Idzko,et al.  Kinetics of Torque Teno Virus-DNA Plasma Load Predict Rejection in Lung Transplant Recipients , 2019, Transplantation.

[6]  E. Puchhammer-Stöckl,et al.  Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients , 2019, The Journal of infectious diseases.

[7]  E. Albert,et al.  Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression‐related complications after kidney transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  E. Puchhammer-Stöckl,et al.  Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients , 2018, The Journal of infectious diseases.

[9]  G. Storch,et al.  Anellovirus loads are associated with outcomes in pediatric lung transplantation , 2018, Pediatric transplantation.

[10]  W. Rabitsch,et al.  Torquetenovirus Dynamics and Immune Marker Properties in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Longitudinal Study. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  R. Kaiser,et al.  Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation , 2017, Medical Microbiology and Immunology.

[12]  N. Mueller,et al.  Torque Teno Virus Load and Acute Rejection After Orthotopic Liver Transplantation. , 2017, Transplantation.

[13]  E. Puchhammer-Stöckl,et al.  Association between plasma Torque teno virus level and chronic lung allograft dysfunction after lung transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  E. Puchhammer-Stöckl,et al.  Torque Teno Virus Load—Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation , 2017, Transplantation.

[15]  A. Pradier,et al.  Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies , 2016, Bone Marrow Transplantation.

[16]  E. Delwart,et al.  Virome analysis of antiretroviral-treated HIV patients shows no correlation between T-cell activation and anelloviruses levels. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  E. Puchhammer-Stöckl,et al.  Pre-Transplant Plasma Torque Teno Virus Load and Increase Dynamics after Lung Transplantation , 2015, PloS one.

[18]  G. Mihăescu,et al.  Human anelloviruses: an update of molecular, epidemiological and clinical aspects , 2015, Archives of Virology.

[19]  U. Boggi,et al.  Short-term kinetics of torque teno virus viraemia after induction immunosuppression confirm T lymphocytes as the main replication-competent cells. , 2015, The Journal of general virology.

[20]  M. Pistello,et al.  Torque Teno virus viremia correlates with intensity of maintenance immunosuppression in adult orthotopic liver transplant. , 2014, The Journal of infectious diseases.

[21]  R. Hotchkiss,et al.  Reactivation of Multiple Viruses in Patients with Sepsis , 2014, PloS one.

[22]  E. Puchhammer-Stöckl,et al.  Plasma DNA levels of Torque teno virus and immunosuppression after lung transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  F. Alvarez,et al.  Torque Teno virus in children who underwent orthotopic liver transplantation: new insights about a common pathogen. , 2014, The Journal of infectious diseases.

[24]  M. Hijikata,et al.  Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus , 2000, Archives of Virology.

[25]  E. de Villiers,et al.  A Human Torque Teno Virus Encodes a MicroRNA That Inhibits Interferon Signaling , 2013, PLoS pathogens.

[26]  N. Neff,et al.  Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy , 2013, Cell.

[27]  G. Weinstock,et al.  Increased Prevalence of Anellovirus in Pediatric Patients with Fever , 2012, PloS one.

[28]  Susan L Furth,et al.  New equations to estimate GFR in children with CKD. , 2009, Journal of the American Society of Nephrology : JASN.

[29]  M. Zorzi,et al.  Torque Teno virus: any pathological role in liver transplanted patients? , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[30]  J. Fishman.  Infection in solid-organ transplant recipients. , 2007, The New England journal of medicine.

[31]  T. Nishizawa,et al.  Development of PCR Assays with Nested Primers Specific for Differential Detection of Three Human Anelloviruses and Early Acquisition of Dual or Triple Infection during Infancy , 2007, Journal of Clinical Microbiology.

[32]  M. Degré,et al.  Effect of immune modulation on TT virus (TTV) and TTV‐like‐mini‐virus (TLMV) viremia , 2003, Journal of medical virology.

[33]  K. Ole,et al.  TTV Viral Load As a Marker for Immune Reconstitution After Initiation of HAART in HIV-Infected Patients , 2002 .

[34]  O. Kirk,et al.  TTV Viral Load As a Marker for Immune Reconstitution After Initiation of HAART in HIV-Infected Patients , 2002, HIV clinical trials.

[35]  W. Yeo,et al.  Gross Elevation of TT Virus Genome Load in the Peripheral Blood Mononuclear Cells of Cancer Patients , 2001, Annals of the New York Academy of Sciences.

[36]  T. Nishizawa,et al.  Inverse relationship between the titre of TT virus DNA and the CD4 cell count in patients infected with HIV , 2001, AIDS.

[37]  D. Shang,et al.  Detection of TT virus DNA in patients with liver disease and recipients of liver transplant , 2000, Journal of medical virology.